_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
My Account
BSE Live
Feb 26, 16:00Prev. Close
269.30
Open Price
268.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 26, 15:54Prev. Close
268.75
Open Price
268.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Nine Months Results of Nath Bio-Genes (in Rs. Cr.) | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
| Net Sales/Income from operations | 252.55 | 219.74 | 178.62 | 141.64 | 118.96 | |
| Other Operating Income | -- | 1.33 | 1.85 | 0.13 | -- | |
| Total Income From Operations | 252.55 | 221.08 | 180.47 | 141.77 | 118.96 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 103.32 | 109.87 | 83.47 | 43.18 | 55.94 | |
| Purchase of Traded Goods | 5.39 | 4.00 | 2.66 | 1.63 | -- | |
| Increase/Decrease in Stocks | 3.39 | -18.46 | -8.88 | 19.49 | -6.32 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 14.01 | 12.52 | 15.52 | 11.74 | 11.66 | |
| Depreciation | 2.01 | 1.10 | 1.05 | 0.75 | 2.63 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | 48.04 | 32.93 | 22.55 | 25.40 | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 70.85 | 15.81 | 14.48 | 6.30 | 4.19 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 53.57 | 48.19 | 39.25 | 36.12 | 25.45 | |
| Other Income | 1.77 | -- | -- | -- | 0.36 | |
| P/L Before Int., Excpt. Items & Tax | 55.35 | 48.19 | 39.25 | 36.12 | 25.81 | |
| Interest | 6.09 | 4.85 | 4.86 | 8.26 | 6.74 | |
| P/L Before Exceptional Items & Tax | 49.26 | 43.34 | 34.39 | 27.87 | 19.07 | |
| Exceptional Items | -- | -- | -- | 0.14 | -- | |
| P/L Before Tax | 49.26 | 43.34 | 34.39 | 28.00 | 19.07 | |
| Tax | 0.74 | 0.48 | 1.27 | 0.33 | 0.60 | |
| P/L After Tax from Ordinary Activities | 48.52 | 42.85 | 33.12 | 27.68 | 18.47 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | 0.00 | |
| Net Profit/(Loss) For the Period | 48.52 | 42.85 | 33.12 | 27.68 | 18.47 | |
| Equity Share Capital | 19.00 | 19.00 | 19.00 | 16.00 | 16.00 | |
| Reserves Excluding Revaluation Reserves | -- | 531.43 | 483.35 | 149.26 | 123.77 | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 25.53 | 22.55 | 17.43 | 17.29 | 11.54 | |
| Diluted EPS | 25.53 | 22.55 | 17.43 | 17.29 | 11.54 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 25.53 | 22.55 | 17.43 | 17.29 | 11.54 | |
| Diluted EPS. | 25.53 | 22.55 | 17.43 | 17.29 | 11.54 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | 0.78 | |
| Share Holding (%) | -- | -- | -- | -- | 48.72 | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | 0.64 | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | 78.17 | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | 40.09 | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | 0.18 | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | 21.83 | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | 11.19 |
10.02.2021
Nath Bio-Genes Standalone December 2020 Net Sales at Rs 36.03 crore, up 7.75% Y-o-Y
10.08.2020
Nath Bio-Genes Standalone June 2020 Net Sales at Rs 193.25 crore, up 16.45% Y-o-Y
10.08.2020
Nath Bio-Genes Standalone June 2020 Net Sales at Rs 193.25 crore, up 16.45% Y-o-Y
16.06.2020
Nath Bio-Genes Standalone March 2020 Net Sales at Rs 60.64 crore, up 14.99% Y-o-Y
10.02.2021
Nath Bio-Genes Standalone December 2020 Net Sales at Rs 36.03 crore, up 7.75% Y-o-Y
10.08.2020
Nath Bio-Genes Standalone June 2020 Net Sales at Rs 193.25 crore, up 16.45% Y-o-Y
10.08.2020
Nath Bio-Genes Standalone June 2020 Net Sales at Rs 193.25 crore, up 16.45% Y-o-Y
16.06.2020
Nath Bio-Genes Standalone March 2020 Net Sales at Rs 60.64 crore, up 14.99% Y-o-Y
